IVX buys Precision centers

IVX Health, a national provider of infusion and injection therapy for patients with chronic conditions such as multiple sclerosis, Crohn’s disease, and rheumatoid arthritis, has acquired Precision Healthcare, formerly a subsidiary of BAI Healthcare Services Inc.

Precision operates 12 infusion centers in Tennessee and northern Arkansas, including one in Chattanooga.

For more than 20 years, Precision has cared for patients with autoimmune disorders and other conditions.

“The Precision team has built an amazing company that shares the same passion and commitment as IVX Health for caring for those with complex chronic conditions,” said Doug Ghertner, CEO of IVX Health. “Together we have the opportunity to meaningfully impact the lives of even more patients by investing in Precision’s existing footprint in ways that expand patient access and enhance the overall patient experience.”

With the completion of the acquisition, IVX Health is now one of the largest providers of infusion and injection therapy in the nation, operating more than 40 ambulatory infusion centers across the United States.

“It’s been a challenging year for the nation, but also a remarkable one for healthcare innovation, particularly for those focused on patient safety in an ever-connected world,” said Dave Schulte, managing director of McKesson Ventures. “As care continues to transition away from the hospital, this acquisition enables IVX Health to better support the growing population of patients receiving biologic infusion or injection therapy.”